The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity

Sheila Miknyoczki, Bruce Ruggeri, Jennifer V. Grobelny et al.|Molecular Cancer Therapeutics|2007

Cited by 112